Navigation Links
NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance
Date:11/1/2007

eceivable 16,927 15,534

Other current assets 4,037 6,082

Plant and equipment, net of accumulated

depreciation and amortization 337 19,849

Debt issuance costs 8,248 5,569

Other assets, net of accumulated amortization 13,465 9,633

Total assets $361,489 $224,740

Liabilities and Stockholders' Equity (Deficit)

Current liabilities $28,927 $25,423

Current notes payable 191,265 19,044

Long-term notes payable and other liabilities 350,995 373,517

Total liabilities 571,187 417,984

Paid-in capital and common stock 681,536 677,520

Accumulated other comprehensive loss (500) (1,892)

Accumulated deficit (890,734) (868,872)

Net stockholders' deficit (209,698) (193,244)

Total liabilities and stockholders' deficit $361,489 $224,740

About NPS Pharmaceuticals

NPS develops small molecules and recombinant proteins as drugs, primarily for the treatment of metabolic, bone and mineral, and central nervous system disorders. The company has drug candidates in various stages of clinical development. Additional information is available on the company's website, http://www.npsp.com.

Conference Call Information

A conference call will be held today at 5:00 p.m. ET. To participate in the call, dial (866) 770-7051 with passcode 53288322. International callers may dial (617) 213-8064 using the same passcode. In addition, live audio of the conference call will be simultaneously broadcast over the Internet
'/>"/>

SOURCE NPS Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
4. Sonic Foundry reports GAAP loss as Q2 revenues rise
5. Fiserv reports $113.5 million in Q1 profit
6. Third Wave reports net loss of $18.9M for 2006
7. Musicnotes reports 45 percent growth in 2006
8. Sonic Foundry reports net loss, higher revenue
9. Sonic Foundry reports first cash-positive quarter
10. Merge Healthcare reports $10.8M net loss in Q3
11. Third Wave reports $5.2M third quarter loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... ANN ARBOR, Mich. , Aug. 26, 2014 ... pioneering the development of breakthrough oral medicines to ... science of immune modulation, today announced the appointment ... of the company,s scientific advisory board.  Dr. Singh ... and insight to advance Lycera,s multiple ongoing research ...
(Date:8/26/2014)... , Aug. 26, 2014 Trovagene, Inc. ... Generation Dx Summit; Moving Assays to the Clinic ... and Monitoring of Cell Free Tumor DNA in ... component of its Precision Cancer Monitoring (PCM) platform ... sensitivity for the detection of tumor DNA mutations ...
(Date:8/26/2014)... Cary, NC (PRWEB) August 26, 2014 ... built-in GMP processes, implemented a new pricing structure with ... better comply with cGMP and 21 CFR Part 11 ... Good Manufacturing Practices any way we can” said Rick ... the number of available users allowed customers to have ...
(Date:8/26/2014)... Ontario (PRWEB) August 26, 2014 ... Shah as its Director of Business Development. Mr. ... Spartan RX CYP2C19 System in the ... responsible for new business opportunities and strategic initiatives ... Prior to joining Spartan, Mr. Shah was the ...
Breaking Biology Technology:Lycera Appoints Harinder Singh, Ph.D., as Chair of Scientific Advisory Board 2Lycera Appoints Harinder Singh, Ph.D., as Chair of Scientific Advisory Board 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4Spartan Bioscience Names Charudutt Shah as Director of Business Development 2
... , NEW YORK , July 27 ... announced the completion of a $5 million round ... Alleghany Corporation (N Y SE: Y), and other investors. ... leading position in the global online patent validation sector by ...
... /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) will conduct a conference call ... 2010 at 4:30 p.m. Eastern time ( 1:30 p.m. Pacific ... To participate in the ... 287-9361 (International). In addition, the call will be webcast live and can be ...
... physicists and materials scientists at the University of ... to rapidly grow centimeter-scale membranes of binary nanocrystal ... nanocrystals on a liquid surface. The study ... long-range-ordered BNSL membranes with rigorous control of nanocrystal ...
Cached Biology Technology:Article One Announces Completion of Funding from Alleghany Corporation 2Article One Announces Completion of Funding from Alleghany Corporation 3Penn collaboration leads to simpler method for building varieties of nanocrystal superlattices 2Penn collaboration leads to simpler method for building varieties of nanocrystal superlattices 3
(Date:8/25/2014)... PULLMAN, Wash.Five years ago this month, one of the ... the Washington State University campus, striking some 2,000 people. ... trove of data gathered at the time to gain ... launch the virus,s rapid spread across the university community., ... first cases came in to the university,s Health and ...
(Date:8/25/2014)... Researchers at the University of California, San Diego School of ... certain glioblastomas the primary form of a deadly brain ... not in the DNA sequence of the tumor, but in ... a priority report in the journal Oncotarget . ... by sequencing the DNA of the cancer cell," said Clark ...
(Date:8/25/2014)... family of proteins that promotes virus entry into cells ... HIV and other viruses, University of Missouri researchers have ... new insights into our understanding of not only HIV ... said Shan-Lu Liu, M.D., Ph.D., associate professor in the ... Immunology. , The study was recently published in the ...
Breaking Biology News(10 mins):WSU flu outbreak provides rare study material 2WSU flu outbreak provides rare study material 3Finding keys to glioblastoma therapeutic resistance 2MU researchers discover protein's ability to inhibit HIV release 2MU researchers discover protein's ability to inhibit HIV release 3
... shines a blue light on yeast and mammalian cells in her ... The effect is the result of a light-activated switch from a ... use this novel "on-off switch" to control cell growth or death, ... cells, said Tucker, an assistant research professor in the biology department ...
... The ocean surface is 30 percent more acidic today than it ... 50 years - a rising trend that could both harm coral ... the ocean food web, scientists warn. Despite the seriousness of ... deploy a complete suite of available tools to monitor rising acidification ...
... have found new evidence linking "Snowball Earth" glacial events to ... the National Science Foundation (NSF). Study results appear in ... The controversial Snowball Earth hypothesis posits that, on several occasions, ... thick sheet of ice lasting for millions of years. ...
Cached Biology News:Researchers could use plant's light switch to control cells 2Speed installation of system to monitor vital signs of global ocean, scientists urge 2Speed installation of system to monitor vital signs of global ocean, scientists urge 3Speed installation of system to monitor vital signs of global ocean, scientists urge 4Speed installation of system to monitor vital signs of global ocean, scientists urge 5Speed installation of system to monitor vital signs of global ocean, scientists urge 6Speed installation of system to monitor vital signs of global ocean, scientists urge 7Speed installation of system to monitor vital signs of global ocean, scientists urge 8Animal evolution springs from 'Snowball Earth' 2
...
Phospho-Btk (Tyr223) Antibody...
...
... to Ki67 - Proliferation Marker, prediluted ... related nuclear protein, expressed by proliferating cells ... cycle (G1, S, G2 and M phase). ... Ki67 antibodies are useful in establishing the ...
Biology Products: